SEC Form 4 · accession 0001171843-15-000650
Anika Therapeutics, Inc. · ANIK
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Francesco J Luppino
Officer — Chief Operating Officer
Period of report
Feb 3, 2015
Accepted (ET)
Feb 5, 2015 · 5:07 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000898437
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $39.69 | Feb 3, 2015 | A | 3,100 | A | — | Feb 3, 2025 | Common Stock | 3,100 | — | D |
Explanation of responses
- F1The stock options vest in four equal annual installments beginning February 3, 2016.